DHG Pharmaceutical JSC (HOSE:DHG)

Market Cap	13.07T +4.4%
Revenue (ttm)	5.27T +9.3%
Net Income	872.74B +9.6%
EPS	6,675.06 +9.7%
Shares Out	130.75M
PE Ratio	14.98
Forward PE	12.91
Dividend	10,000.00 (10.00%)
Ex-Dividend Date	May 11, 2026

Volume	24,876
Average Volume	14,584
Open	99,800
Previous Close	99,700
Day's Range	99,500 - 100,000
52-Week Range	96,600 - 110,700
Beta	0.32
RSI	46.70
Earnings Date	Apr 17, 2026

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceutical...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,806
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2025, DHG Pharmaceutical JSC's revenue was 5.27 trillion, an increase of 7.82% compared to the previous year's 4.88 trillion. Earnings were 824.78 billion, an increase of 9.45%.